Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 27 | 2023 | 759 | 4.130 |
Why?
|
Thoracic Vertebrae | 24 | 2019 | 604 | 3.580 |
Why?
|
Lumbar Vertebrae | 28 | 2022 | 1844 | 2.860 |
Why?
|
Spinal Cord Injuries | 15 | 2019 | 930 | 2.450 |
Why?
|
Spinal Fusion | 24 | 2022 | 1234 | 2.400 |
Why?
|
Neurosurgical Procedures | 29 | 2020 | 2002 | 2.310 |
Why?
|
Laminectomy | 10 | 2019 | 232 | 2.160 |
Why?
|
Spine | 18 | 2023 | 1143 | 1.990 |
Why?
|
Spinal Stenosis | 6 | 2022 | 255 | 1.880 |
Why?
|
Neurosurgery | 12 | 2019 | 642 | 1.880 |
Why?
|
Spondylolisthesis | 7 | 2022 | 162 | 1.710 |
Why?
|
Spinal Cord Neoplasms | 9 | 2016 | 281 | 1.690 |
Why?
|
Spinal Injuries | 13 | 2021 | 301 | 1.580 |
Why?
|
Spinal Cord Diseases | 6 | 2022 | 299 | 1.530 |
Why?
|
Spinal Cord Compression | 7 | 2019 | 235 | 1.510 |
Why?
|
Spinal Fractures | 13 | 2021 | 698 | 1.410 |
Why?
|
Pneumocephalus | 2 | 2020 | 46 | 1.400 |
Why?
|
Cervical Vertebrae | 10 | 2019 | 973 | 1.380 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 90 | 1.320 |
Why?
|
Decompression, Surgical | 11 | 2020 | 593 | 1.230 |
Why?
|
Epidural Space | 4 | 2016 | 124 | 1.180 |
Why?
|
Radiculopathy | 4 | 2015 | 194 | 1.150 |
Why?
|
Astrocytoma | 6 | 2018 | 789 | 1.120 |
Why?
|
Sciatica | 2 | 2017 | 98 | 1.000 |
Why?
|
Dura Mater | 3 | 2018 | 291 | 0.840 |
Why?
|
Nerve Regeneration | 3 | 2013 | 791 | 0.830 |
Why?
|
Gait | 3 | 2016 | 784 | 0.820 |
Why?
|
Spinal Diseases | 8 | 2017 | 538 | 0.820 |
Why?
|
Meningioma | 4 | 2023 | 1209 | 0.820 |
Why?
|
Meningeal Neoplasms | 4 | 2023 | 1241 | 0.800 |
Why?
|
Ependymoma | 4 | 2018 | 333 | 0.790 |
Why?
|
Lidocaine | 2 | 2014 | 542 | 0.760 |
Why?
|
Arachnoid Cysts | 2 | 2018 | 59 | 0.760 |
Why?
|
Peripheral Nerves | 2 | 2015 | 474 | 0.680 |
Why?
|
Epidural Neoplasms | 1 | 2018 | 24 | 0.660 |
Why?
|
Chondrosarcoma | 2 | 2023 | 309 | 0.660 |
Why?
|
Spondylosis | 1 | 2019 | 81 | 0.660 |
Why?
|
Surgical Mesh | 1 | 2021 | 256 | 0.650 |
Why?
|
Vertebroplasty | 2 | 2011 | 77 | 0.640 |
Why?
|
Craniotomy | 6 | 2020 | 729 | 0.630 |
Why?
|
Recovery of Function | 5 | 2015 | 2924 | 0.600 |
Why?
|
Hemangioma, Cavernous | 1 | 2018 | 110 | 0.590 |
Why?
|
Communication Aids for Disabled | 1 | 2017 | 56 | 0.590 |
Why?
|
Anesthetics, Local | 2 | 2014 | 984 | 0.580 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2018 | 181 | 0.570 |
Why?
|
Manipulation, Spinal | 1 | 2016 | 21 | 0.550 |
Why?
|
Spinal Cord | 5 | 2018 | 1807 | 0.550 |
Why?
|
Medical Tourism | 1 | 2016 | 57 | 0.530 |
Why?
|
Odontoid Process | 2 | 2015 | 47 | 0.520 |
Why?
|
Brain Injuries | 4 | 2013 | 2024 | 0.520 |
Why?
|
Glucocorticoids | 2 | 2015 | 2107 | 0.520 |
Why?
|
Bone Substitutes | 1 | 2017 | 229 | 0.510 |
Why?
|
Evidence-Based Medicine | 16 | 2021 | 3611 | 0.510 |
Why?
|
Stem Cell Transplantation | 4 | 2016 | 1618 | 0.500 |
Why?
|
Schwann Cells | 1 | 2015 | 195 | 0.490 |
Why?
|
Humans | 141 | 2023 | 742088 | 0.490 |
Why?
|
Methylprednisolone | 2 | 2019 | 388 | 0.490 |
Why?
|
Myelin Proteins | 1 | 2015 | 215 | 0.490 |
Why?
|
Electric Stimulation Therapy | 3 | 2016 | 605 | 0.480 |
Why?
|
Epidural Abscess | 1 | 2015 | 84 | 0.470 |
Why?
|
Locomotion | 3 | 2012 | 378 | 0.460 |
Why?
|
Cryosurgery | 1 | 2018 | 453 | 0.460 |
Why?
|
Lumbosacral Region | 5 | 2021 | 310 | 0.450 |
Why?
|
Pyramidal Tracts | 1 | 2015 | 257 | 0.440 |
Why?
|
Osteotomy | 2 | 2016 | 823 | 0.440 |
Why?
|
Fractures, Spontaneous | 2 | 2019 | 230 | 0.430 |
Why?
|
Neurilemmoma | 1 | 2018 | 547 | 0.420 |
Why?
|
Corynebacterium Infections | 1 | 2011 | 27 | 0.400 |
Why?
|
Simvastatin | 1 | 2014 | 360 | 0.390 |
Why?
|
Insurance, Liability | 1 | 2011 | 102 | 0.390 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2014 | 350 | 0.380 |
Why?
|
Intracranial Pressure | 1 | 2013 | 326 | 0.380 |
Why?
|
Decompressive Craniectomy | 1 | 2011 | 72 | 0.370 |
Why?
|
Cerebral Arteries | 2 | 2012 | 492 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2016 | 9941 | 0.370 |
Why?
|
Subdural Space | 2 | 2020 | 32 | 0.370 |
Why?
|
Chondroitin ABC Lyase | 1 | 2010 | 17 | 0.370 |
Why?
|
Magnetic Field Therapy | 1 | 2010 | 28 | 0.370 |
Why?
|
Spleen | 1 | 2016 | 2359 | 0.370 |
Why?
|
Off-Label Use | 1 | 2011 | 169 | 0.360 |
Why?
|
Fractures, Compression | 2 | 2011 | 134 | 0.360 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2012 | 647 | 0.350 |
Why?
|
Abscess | 2 | 2022 | 607 | 0.340 |
Why?
|
Hemangioblastoma | 3 | 2006 | 70 | 0.340 |
Why?
|
Secondary Prevention | 1 | 2016 | 1520 | 0.340 |
Why?
|
Muscle Contraction | 1 | 2014 | 1241 | 0.340 |
Why?
|
Hemangioma | 3 | 2016 | 737 | 0.330 |
Why?
|
Serotonin Receptor Agonists | 1 | 2009 | 154 | 0.330 |
Why?
|
Low Back Pain | 3 | 2016 | 955 | 0.330 |
Why?
|
Diphosphonates | 1 | 2013 | 625 | 0.330 |
Why?
|
Paralysis | 1 | 2010 | 249 | 0.330 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1638 | 0.330 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3507 | 0.330 |
Why?
|
Vancomycin | 1 | 2012 | 500 | 0.320 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 495 | 0.320 |
Why?
|
Treatment Outcome | 29 | 2022 | 62966 | 0.320 |
Why?
|
Postoperative Complications | 10 | 2020 | 15244 | 0.320 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 161 | 0.320 |
Why?
|
Hindlimb | 1 | 2009 | 505 | 0.310 |
Why?
|
Nucleic Acids | 1 | 2010 | 181 | 0.300 |
Why?
|
ADP-Ribosylation Factors | 1 | 2008 | 133 | 0.300 |
Why?
|
Internal Fixators | 4 | 2021 | 188 | 0.300 |
Why?
|
Motor Cortex | 1 | 2015 | 984 | 0.300 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1737 | 0.300 |
Why?
|
Hematoma | 1 | 2012 | 755 | 0.300 |
Why?
|
Diskectomy | 2 | 2013 | 206 | 0.300 |
Why?
|
Multicenter Studies as Topic | 4 | 2013 | 1661 | 0.290 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2637 | 0.290 |
Why?
|
Malpractice | 1 | 2011 | 569 | 0.280 |
Why?
|
Posterior Cerebral Artery | 1 | 2006 | 24 | 0.280 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1285 | 0.280 |
Why?
|
Conflict of Interest | 1 | 2011 | 542 | 0.280 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 774 | 0.280 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 80 | 0.270 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 941 | 0.270 |
Why?
|
Sphenoid Sinus | 1 | 2006 | 100 | 0.270 |
Why?
|
Glioma | 4 | 2016 | 3388 | 0.270 |
Why?
|
Paraplegia | 2 | 2016 | 168 | 0.270 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2275 | 0.260 |
Why?
|
Aged | 37 | 2022 | 162944 | 0.260 |
Why?
|
Occipital Lobe | 1 | 2006 | 380 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2714 | 0.240 |
Why?
|
Male | 49 | 2021 | 349538 | 0.240 |
Why?
|
Neurology | 1 | 2012 | 762 | 0.240 |
Why?
|
Brain Neoplasms | 7 | 2016 | 8829 | 0.240 |
Why?
|
Cranial Fossa, Anterior | 1 | 2003 | 13 | 0.230 |
Why?
|
Joint Prosthesis | 1 | 2005 | 257 | 0.230 |
Why?
|
Guidelines as Topic | 9 | 2019 | 1402 | 0.230 |
Why?
|
Middle Aged | 39 | 2022 | 213127 | 0.230 |
Why?
|
Female | 53 | 2021 | 379592 | 0.230 |
Why?
|
Carotid Artery, Internal | 1 | 2006 | 445 | 0.230 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 2006 | 0.230 |
Why?
|
Neuralgia | 1 | 2010 | 568 | 0.230 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7276 | 0.230 |
Why?
|
Patient Care Planning | 2 | 2019 | 921 | 0.220 |
Why?
|
Preoperative Care | 3 | 2020 | 2245 | 0.210 |
Why?
|
Adult | 35 | 2023 | 213712 | 0.210 |
Why?
|
Arthrodesis | 3 | 2019 | 187 | 0.210 |
Why?
|
Radiation Dosage | 1 | 2011 | 1927 | 0.210 |
Why?
|
Streptococcus anginosus | 1 | 2022 | 24 | 0.210 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1538 | 0.210 |
Why?
|
Back Pain | 3 | 2022 | 545 | 0.210 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1144 | 0.210 |
Why?
|
Brain Edema | 1 | 2006 | 617 | 0.200 |
Why?
|
Neurofibromatoses | 1 | 2006 | 299 | 0.200 |
Why?
|
Vascular Surgical Procedures | 3 | 2008 | 1473 | 0.200 |
Why?
|
Skin | 1 | 2015 | 4353 | 0.200 |
Why?
|
Arthroplasty, Replacement | 1 | 2005 | 336 | 0.200 |
Why?
|
Rats | 9 | 2016 | 24265 | 0.200 |
Why?
|
Facial Injuries | 1 | 2022 | 183 | 0.200 |
Why?
|
Biopsy | 1 | 2013 | 6756 | 0.190 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2643 | 0.190 |
Why?
|
Occupational Exposure | 1 | 2011 | 1794 | 0.190 |
Why?
|
Retrospective Studies | 24 | 2023 | 77098 | 0.190 |
Why?
|
Hypotension | 1 | 2006 | 880 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2008 | 1983 | 0.180 |
Why?
|
Scoliosis | 1 | 2007 | 719 | 0.180 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2019 | 19 | 0.180 |
Why?
|
Intracranial Aneurysm | 2 | 2006 | 1197 | 0.180 |
Why?
|
Computers, Handheld | 1 | 2022 | 208 | 0.180 |
Why?
|
Pain Measurement | 3 | 2021 | 3418 | 0.180 |
Why?
|
Wounds, Nonpenetrating | 1 | 2006 | 794 | 0.180 |
Why?
|
Hydrocephalus | 2 | 2009 | 746 | 0.180 |
Why?
|
Frontal Lobe | 1 | 2006 | 1407 | 0.180 |
Why?
|
Orthopedic Procedures | 4 | 2018 | 1288 | 0.170 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2522 | 0.170 |
Why?
|
Disability Evaluation | 1 | 2006 | 1827 | 0.170 |
Why?
|
Cadaver | 2 | 2022 | 1333 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3239 | 0.170 |
Why?
|
Research Design | 2 | 2012 | 5979 | 0.170 |
Why?
|
Animals | 20 | 2016 | 168561 | 0.170 |
Why?
|
Subarachnoid Space | 1 | 2018 | 79 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20086 | 0.150 |
Why?
|
Walking | 2 | 2019 | 1177 | 0.150 |
Why?
|
Pain | 4 | 2018 | 4961 | 0.150 |
Why?
|
Bone Nails | 3 | 2007 | 219 | 0.150 |
Why?
|
Punctures | 1 | 2018 | 372 | 0.150 |
Why?
|
Combined Modality Therapy | 3 | 2023 | 8621 | 0.150 |
Why?
|
Prospective Studies | 10 | 2022 | 53187 | 0.140 |
Why?
|
Chordoma | 2 | 2012 | 359 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 13 | 2022 | 35342 | 0.140 |
Why?
|
Prognosis | 6 | 2020 | 29010 | 0.140 |
Why?
|
Patient Selection | 4 | 2018 | 4214 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17400 | 0.140 |
Why?
|
Aged, 80 and over | 14 | 2022 | 57683 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1385 | 0.140 |
Why?
|
Vision Disorders | 1 | 2003 | 1057 | 0.140 |
Why?
|
Fracture Fixation, Internal | 2 | 2019 | 916 | 0.130 |
Why?
|
Neurologic Examination | 1 | 2019 | 931 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 656 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12242 | 0.130 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 175 | 0.120 |
Why?
|
Osteomyelitis | 1 | 2018 | 402 | 0.120 |
Why?
|
Morphine | 1 | 2018 | 657 | 0.120 |
Why?
|
Glioblastoma | 2 | 2016 | 3456 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1640 | 0.120 |
Why?
|
Medulla Oblongata | 1 | 2015 | 243 | 0.120 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7153 | 0.120 |
Why?
|
Neuroendoscopy | 1 | 2015 | 105 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 300 | 0.110 |
Why?
|
Sulfotransferases | 1 | 2014 | 151 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18006 | 0.110 |
Why?
|
Injections, Epidural | 1 | 2015 | 195 | 0.110 |
Why?
|
Glasgow Coma Scale | 2 | 2021 | 570 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1369 | 0.110 |
Why?
|
Aging | 2 | 2009 | 8626 | 0.110 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1095 | 0.110 |
Why?
|
Body Temperature | 1 | 2016 | 776 | 0.110 |
Why?
|
Young Adult | 11 | 2022 | 56350 | 0.110 |
Why?
|
Age Distribution | 3 | 2009 | 2900 | 0.110 |
Why?
|
Physicians | 1 | 2011 | 4554 | 0.110 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2012 | 11 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 983 | 0.110 |
Why?
|
Powders | 1 | 2012 | 80 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2016 | 1093 | 0.100 |
Why?
|
Fluoroscopy | 2 | 2018 | 924 | 0.100 |
Why?
|
Analgesics | 1 | 2018 | 1037 | 0.100 |
Why?
|
Giant Cell Tumors | 1 | 2012 | 99 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15056 | 0.100 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13019 | 0.100 |
Why?
|
Exophthalmos | 1 | 2011 | 96 | 0.100 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 341 | 0.100 |
Why?
|
Logistic Models | 3 | 2019 | 13403 | 0.090 |
Why?
|
Observation | 1 | 2012 | 312 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 626 | 0.090 |
Why?
|
Medical Illustration | 2 | 2008 | 133 | 0.090 |
Why?
|
Joint Instability | 1 | 2018 | 792 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2017 | 1426 | 0.090 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 65 | 0.090 |
Why?
|
Brain | 2 | 2017 | 26343 | 0.090 |
Why?
|
Arthroplasty | 2 | 2022 | 305 | 0.090 |
Why?
|
Cohort Studies | 6 | 2020 | 40450 | 0.090 |
Why?
|
Efferent Pathways | 1 | 2010 | 167 | 0.090 |
Why?
|
Radiotherapy | 3 | 2017 | 1525 | 0.090 |
Why?
|
Weight-Bearing | 2 | 2009 | 514 | 0.090 |
Why?
|
Mortality | 2 | 2019 | 2857 | 0.090 |
Why?
|
Pinealoma | 1 | 2009 | 54 | 0.090 |
Why?
|
Injections, Spinal | 1 | 2010 | 303 | 0.090 |
Why?
|
Carcinoma | 2 | 2019 | 2374 | 0.090 |
Why?
|
Motor Neurons | 1 | 2014 | 851 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2016 | 847 | 0.090 |
Why?
|
Databases, Factual | 2 | 2014 | 7716 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1608 | 0.080 |
Why?
|
Reoperation | 2 | 2016 | 4200 | 0.080 |
Why?
|
Time | 2 | 2020 | 530 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2450 | 0.080 |
Why?
|
Hemifacial Spasm | 1 | 2008 | 23 | 0.080 |
Why?
|
Pineal Gland | 1 | 2009 | 165 | 0.080 |
Why?
|
Glycosaminoglycans | 1 | 2012 | 624 | 0.080 |
Why?
|
Cerebellopontine Angle | 1 | 2008 | 55 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 491 | 0.080 |
Why?
|
Hemodynamics | 1 | 2019 | 4197 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2271 | 0.080 |
Why?
|
Electromagnetic Fields | 1 | 2010 | 298 | 0.080 |
Why?
|
Blotting, Northern | 2 | 2008 | 1581 | 0.080 |
Why?
|
Polyribosomes | 1 | 2008 | 110 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8333 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 838 | 0.080 |
Why?
|
Electromyography | 2 | 2009 | 1391 | 0.080 |
Why?
|
Genomics | 1 | 2023 | 5692 | 0.080 |
Why?
|
Ribs | 1 | 2008 | 250 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2006 | 28 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2009 | 939 | 0.070 |
Why?
|
Gravitation | 1 | 2006 | 82 | 0.070 |
Why?
|
Brain Abscess | 1 | 2007 | 118 | 0.070 |
Why?
|
Temporal Muscle | 1 | 2006 | 37 | 0.070 |
Why?
|
Survival Analysis | 5 | 2023 | 10248 | 0.070 |
Why?
|
Bone Screws | 2 | 2007 | 519 | 0.070 |
Why?
|
Calcium Channels | 1 | 2010 | 621 | 0.070 |
Why?
|
Pain Threshold | 1 | 2010 | 585 | 0.070 |
Why?
|
Lipoma | 1 | 2008 | 334 | 0.070 |
Why?
|
Hyperalgesia | 1 | 2010 | 502 | 0.070 |
Why?
|
Sella Turcica | 1 | 2006 | 119 | 0.070 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2006 | 56 | 0.070 |
Why?
|
Tissue Transplantation | 1 | 2006 | 130 | 0.070 |
Why?
|
Hematoma, Subdural, Spinal | 1 | 2005 | 8 | 0.070 |
Why?
|
Sex Distribution | 2 | 2008 | 2295 | 0.060 |
Why?
|
Sphenoid Bone | 1 | 2006 | 172 | 0.060 |
Why?
|
Quality Improvement | 2 | 2020 | 3738 | 0.060 |
Why?
|
Genes, ras | 1 | 2008 | 691 | 0.060 |
Why?
|
Algorithms | 1 | 2005 | 13853 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2018 | 39004 | 0.060 |
Why?
|
Trauma Severity Indices | 1 | 2006 | 481 | 0.060 |
Why?
|
von Hippel-Lindau Disease | 1 | 2006 | 152 | 0.060 |
Why?
|
Video Recording | 1 | 2009 | 944 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1675 | 0.060 |
Why?
|
Cicatrix | 1 | 2010 | 761 | 0.060 |
Why?
|
Time Factors | 5 | 2016 | 40054 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3276 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 692 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12958 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19862 | 0.060 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 160 | 0.060 |
Why?
|
Cerebellar Neoplasms | 1 | 2008 | 585 | 0.060 |
Why?
|
Oximetry | 1 | 2006 | 467 | 0.060 |
Why?
|
Review Literature as Topic | 1 | 2005 | 333 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2005 | 339 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 2019 | 20774 | 0.060 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 396 | 0.060 |
Why?
|
Communication | 1 | 2017 | 3728 | 0.060 |
Why?
|
Arteriovenous Fistula | 1 | 2006 | 315 | 0.050 |
Why?
|
Emergency Treatment | 1 | 2006 | 517 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3667 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 1973 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3869 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3111 | 0.050 |
Why?
|
Length of Stay | 2 | 2020 | 6294 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3258 | 0.050 |
Why?
|
Exercise Test | 1 | 2009 | 2075 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 6534 | 0.050 |
Why?
|
Blotting, Western | 2 | 2008 | 5180 | 0.050 |
Why?
|
Electroencephalography | 1 | 2017 | 6142 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6608 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1418 | 0.050 |
Why?
|
Risk Assessment | 5 | 2020 | 23320 | 0.050 |
Why?
|
Risk Factors | 6 | 2020 | 72145 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3300 | 0.050 |
Why?
|
Gliosarcoma | 1 | 2001 | 114 | 0.050 |
Why?
|
Adolescent | 9 | 2022 | 85649 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3504 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1562 | 0.050 |
Why?
|
Thymidine Kinase | 2 | 2016 | 290 | 0.050 |
Why?
|
Astrocytes | 1 | 2008 | 1266 | 0.050 |
Why?
|
Longitudinal Ligaments | 1 | 2019 | 27 | 0.050 |
Why?
|
Acute Disease | 1 | 2010 | 7141 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2001 | 152 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3695 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1624 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2290 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1188 | 0.040 |
Why?
|
Agrin | 1 | 1999 | 68 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2502 | 0.040 |
Why?
|
International Classification of Diseases | 2 | 2014 | 865 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 21596 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2005 | 2110 | 0.040 |
Why?
|
England | 1 | 2020 | 523 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 520 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 935 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6347 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.040 |
Why?
|
Receptors, Cholinergic | 1 | 1999 | 238 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3557 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4392 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2007 | 5062 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 3612 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 792 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13655 | 0.040 |
Why?
|
Flucytosine | 1 | 2016 | 32 | 0.040 |
Why?
|
Anticoagulants | 2 | 2019 | 4595 | 0.040 |
Why?
|
Platelet Count | 1 | 2019 | 780 | 0.040 |
Why?
|
Calcium | 1 | 2010 | 5753 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2000 | 1902 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16665 | 0.040 |
Why?
|
Cytosine Deaminase | 1 | 2016 | 68 | 0.040 |
Why?
|
Radiography | 2 | 2008 | 7010 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2016 | 69 | 0.030 |
Why?
|
Enterobiasis | 1 | 1995 | 1 | 0.030 |
Why?
|
Ganciclovir | 1 | 2016 | 259 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 691 | 0.030 |
Why?
|
Analgesia, Epidural | 1 | 2018 | 326 | 0.030 |
Why?
|
Bupivacaine | 1 | 2018 | 408 | 0.030 |
Why?
|
Bone Transplantation | 2 | 2013 | 907 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2010 | 13029 | 0.030 |
Why?
|
Menarche | 1 | 1997 | 513 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1839 | 0.030 |
Why?
|
Enterocolitis | 1 | 1995 | 102 | 0.030 |
Why?
|
Braces | 1 | 2014 | 135 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7721 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2615 | 0.030 |
Why?
|
Child | 4 | 2022 | 77478 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10372 | 0.030 |
Why?
|
Quality of Life | 2 | 2019 | 12730 | 0.030 |
Why?
|
Risk | 1 | 2005 | 9679 | 0.030 |
Why?
|
United States | 5 | 2020 | 69693 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9185 | 0.030 |
Why?
|
Infant | 2 | 2022 | 35070 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 822 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2303 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8425 | 0.030 |
Why?
|
Fluorouracil | 1 | 2016 | 1615 | 0.030 |
Why?
|
Child, Preschool | 2 | 2022 | 40955 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2876 | 0.020 |
Why?
|
Nose | 1 | 2015 | 509 | 0.020 |
Why?
|
Eosinophilia | 1 | 1995 | 531 | 0.020 |
Why?
|
Medicare Part A | 1 | 2011 | 39 | 0.020 |
Why?
|
Lymphoma | 1 | 2019 | 1873 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2016 | 952 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 2001 | 862 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1080 | 0.020 |
Why?
|
Vestibulocochlear Nerve | 1 | 2008 | 116 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 199 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4839 | 0.020 |
Why?
|
Ventriculostomy | 1 | 2009 | 136 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1376 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 20928 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 233 | 0.020 |
Why?
|
Mice | 1 | 2014 | 81045 | 0.020 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2008 | 249 | 0.020 |
Why?
|
Hospital Charges | 1 | 2009 | 362 | 0.020 |
Why?
|
Orthopedic Fixation Devices | 1 | 2007 | 75 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2011 | 720 | 0.020 |
Why?
|
Orthotic Devices | 1 | 2007 | 128 | 0.020 |
Why?
|
Facial Nerve | 1 | 2008 | 271 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4030 | 0.020 |
Why?
|
Rotavirus | 1 | 1987 | 109 | 0.020 |
Why?
|
Sacrum | 1 | 2008 | 289 | 0.020 |
Why?
|
Survival Rate | 2 | 2011 | 12773 | 0.020 |
Why?
|
Immunotherapy | 1 | 2000 | 4414 | 0.020 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2005 | 124 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2018 | 12017 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2005 | 287 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 351 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4249 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 29087 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 29717 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 438 | 0.010 |
Why?
|
Drug Utilization | 1 | 2009 | 1181 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2495 | 0.010 |
Why?
|
California | 1 | 2007 | 1400 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25575 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18355 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1987 | 730 | 0.010 |
Why?
|
Transfection | 2 | 2001 | 5892 | 0.010 |
Why?
|
Antigenic Modulation | 1 | 2001 | 11 | 0.010 |
Why?
|
Blood Vessels | 1 | 2008 | 1124 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2885 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2008 | 953 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8925 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5169 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11001 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1413 | 0.010 |
Why?
|
Hearing Loss | 1 | 2008 | 765 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8077 | 0.010 |
Why?
|
Topotecan | 1 | 2000 | 138 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9715 | 0.010 |
Why?
|
Chromatography, Agarose | 1 | 1999 | 28 | 0.010 |
Why?
|
Receptor Aggregation | 1 | 1999 | 80 | 0.010 |
Why?
|
Microsurgery | 1 | 2005 | 796 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1195 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5385 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1449 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5948 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1577 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4029 | 0.010 |
Why?
|
Basement Membrane | 1 | 1999 | 356 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 1398 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1392 | 0.010 |
Why?
|
Epidemiologic Factors | 1 | 1997 | 30 | 0.010 |
Why?
|
Simplexvirus | 1 | 2001 | 802 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12344 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4771 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1160 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1663 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2085 | 0.010 |
Why?
|
Enterobius | 1 | 1995 | 1 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1224 | 0.010 |
Why?
|
Taiwan | 1 | 1997 | 496 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4187 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1402 | 0.010 |
Why?
|
Anthelmintics | 1 | 1995 | 62 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 427 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1999 | 849 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1606 | 0.010 |
Why?
|
Larva | 1 | 1995 | 517 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4564 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.010 |
Why?
|
Up-Regulation | 1 | 2001 | 4211 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3847 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3862 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3420 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5975 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3266 | 0.010 |
Why?
|
Models, Genetic | 1 | 1999 | 3493 | 0.010 |
Why?
|
Gene Expression | 1 | 2001 | 7790 | 0.000 |
Why?
|
Diarrhea | 1 | 1995 | 1343 | 0.000 |
Why?
|
Colloids | 1 | 1987 | 136 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1987 | 218 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10943 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9846 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12797 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11690 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1987 | 2645 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 19223 | 0.000 |
Why?
|
Gold | 1 | 1987 | 483 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9581 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 18112 | 0.000 |
Why?
|